(Q45017472)

English

On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

gastroesophageal reflux disease

0 references

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

patient satisfaction

1 reference

based on heuristic

inferred from title

(RS)-rabeprazole

0 references

Guillermo Bastida

object named as

Guillermo Bastida

3

0 references

author name string

Julio Ponce

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Lidia Argüello

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Marta Ponce

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Vicente Ortiz

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Vicente Garrigues

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

931-936

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On-demand and intermittent therapy for gastro-oesophageal reflux disease: economic considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of irritable bowel syndrome on health-related quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of esophageal and supraesophageal reflux injuries

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Population reference values of the Spanish version of the Health Questionnaire SF-36]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three year follow up of patients with gastrooesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview: initial and long-term management of gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of gastroesophageal reflux in asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of upper gastrointestinal symptoms in the general population: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endoscopic assessment of esophagitis: a progress report on observer agreement.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evidence-based appraisal of reflux disease management--the Genval Workshop Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On-demand therapy for gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of gastroesophageal reflux disease on health-related quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing compliance in long-term proton pump inhibitor therapy in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15309880

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/B:DDAS.0000034551.39324.C3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45017472&oldid=2207049376"